Adine Axen - Swedish Orphan Insider

BIOVF -- USA Stock  

USD 23.55  1.10  4.90%

Independent Director
Ms. Adine Grate Axen was Independent Member of the Board of Directors of Swedish Orphan Biovitrum AB since April 27 2010. She also serves as Member of the Company Audit Committee. Prior to this she was Member of the Advisory Committee for the Sale of Stateowned Companies Board member of Gambro AB and OMX AB . She held various senior management positions and Board assignments within Investor AB and was member of the management group . She was also Board member of Acne Studios Holding AB Micaro AB Evry AS EDB Ergo Group AS and Carnegie Investment Bank AB. She serves as Chairman of Nasdaq OMX Stockholms Listing Committee and Vice Chairman of the Seventh AP Fund as well as Board member of Sky Ltd Sampo OY HI3GS Holding AB 3GIS Infrastructure Services AB HI3G Denmark ApS Madrague AB and Swedavia AB. She holds a MS degree from Handelshogskolan i Stockholm and has completed Advanced Management Program at Harvard.
Age: 54  Director Since 2010      
46 86 97 20 00  http://www.sobi.com

Management Efficiency

The company has return on total asset (ROA) of 11.67 % which means that it generated profit of $11.67 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 22.83 % meaning that it generated $22.83 on every $100 dollars invested by stockholders.
The company has accumulated 675.6 K in total debt. Swedish Orphan Biovitrum AB has Current Ratio of 1.85 which is within standard range for the sector.

Similar Executives

Entity Summary

Swedish Orphan Biovitrum AB , an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. Swedish Orphan Biovitrum AB is headquartered in Solna, Sweden. Swedish Orphan is traded on OTC Market in USA.Swedish Orphan Biovitrum AB (BIOVF) is traded on OTC Market in USA. It is located in Tomtebodav?gen 23A and employs 816 people.

Swedish Orphan Biovi Leadership Team

Hans Wigzell, Director, Ph.D
Lennart Johansson, Director, MBA
Annette Clancy, Director
Trista Morrison, President
Kirsti Gjellan, President
Jorgen Winroth, VP
Milan Zdravkovic, President, Ph.D
Hans Schikan, Director
Dennis Pedersen, President
Helena Saxon, Director, MBA
Anders Edvell, Executive, MBA
Geoffrey McDonough, CEO, Ph.D
Lars Dreioee, President, MBA
Alan Raffensperger, COO
Fredrik Berg, Executive
BoGunnar Rosenbrand, Director
Adine Axen, Director
Birgitte Volck, President
MatsOlof Wallin, President
Stefan Fraenkel, President, MBA
Hakan Bjorklund, Chairman, Ph.D
Cecilia Forberg, President
Stephen James, President, Ph.D
Bo Hansen, Chairman, Ph.D
Armin Reininger, President, Ph.D
Catarina Larsson, Director
Henrik Stenqvist, CFO
David Allsop, Director
Elisabeth Svanberg, Director
Wills HughesWilson, President
Guido Oelkers, CEO
Jeffrey Jonas, Director, Ph.D
Matthew Gantz, Director, MBA
Theresa Heggie, Director

Stock Performance Indicators

Did you try this?

Run Headlines Timeline Now
   

Headlines Timeline

Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
All  Next Launch Headlines Timeline

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Swedish Orphan and U S Bancorp. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .